We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-5.4%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$496M
AUM Growth
-$67M
(-12%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-2.49%
Top 10 Holdings %
Top 10 Hldgs %
25.38%
Holding
128
New
22
Increased
39
Reduced
44
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icon
ICLR
|
+$7.57M |
| 2 |
iRhythm Holdings
IRTC
|
+$6.12M |
| 3 |
Travere Therapeutics
TVTX
|
+$5.83M |
| 4 |
Lantheus
LNTH
|
+$5.59M |
| 5 |
Alkermes
ALKS
|
+$5.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$12.4M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$8.48M |
| 3 |
Health Catalyst
HCAT
|
+$6.58M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$5.99M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$5.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.62% |
| 2 | Industrials | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Medtronic
MDT
$110B
| $2.29M | 0.46% |
25,551
+3,000
| +13% | +$304K |
|
77
Vertex Pharmaceuticals
VRTX
$122B
| $2.29M | 0.46% |
8,118
+837
| +11% | +$224K |
|
78
Gilead Sciences
GILD
$163B
| $2.25M | 0.45% |
36,400
+11,400
| +46% | +$706K |
|
|
EXAI
79
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $2.19M | 0.44% |
201,388
-34,295
| -15% | -$409K |
|
80
Danaher
DHR
$138B
| $2.19M | 0.44% |
9,729
-7,276
| -43% | -$1.68M |
|
81
Cigna
CI
$76.1B
| $2.06M | 0.41% |
7,800
-2,850
| -27% | -$734K |
|
82
Regeneron Pharmaceuticals
REGN
$77.4B
| $1.9M | 0.38% |
3,210
+170
| +6% | +$111K |
|
83
Alnylam Pharmaceuticals
ALNY
$27.4B
| $1.75M | 0.35% |
12,030
+7,960
| +196% | +$1.13M |
|
84
Altimmune
ALT
$580M
| $1.75M | 0.35% |
+150,000
| New | +$925K |
|
85
Jasper Therapeutics
JSPR
$20.7M
| $1.38M | 0.28% |
71,536
+4,036
| +6% | +$115K |
|
86
AstraZeneca
AZN
$266B
| $1.08M | 0.22% |
+8,205
| New | +$1.08M |
|
|
TRML
87
DELISTED
Tourmaline Bio
TRML
| $1.03M | 0.21% |
22,862
| – | – |
|
|
ONC
88
BeOne Medicines Ltd
ONC
$33.4B
| $822K | 0.17% |
5,080
+500
| +11% | +$78.1K |
|
89
Illumina
ILMN
$31B
| $631K | 0.13% |
3,516
+1,501
| +74% | +$383K |
|
90
Sanofi
SNY
$103B
| $590K | 0.12% |
+11,784
| New | +$625K |
|
91
Royalty Pharma
RPRX
$26.2B
| $582K | 0.12% |
+13,840
| New | +$567K |
|
92
Legend Biotech
LEGN
$3.69B
| $550K | 0.11% |
10,000
-2,000
| -17% | -$84.5K |
|
93
Incyte
INCY
$24.9B
| $538K | 0.11% |
7,080
+1,220
| +21% | +$92.6K |
|
94
Zai Lab
ZLAB
$2.06B
| $486K | 0.1% |
14,000
+2,000
| +17% | +$70.5K |
|
95
argenx
ARGX
$54.6B
| $481K | 0.1% |
+1,270
| New | +$409K |
|
96
Dr. Reddy's Laboratories
RDY
$9.85B
| $471K | 0.09% |
42,520
+17,500
| +70% | +$190K |
|
97
United Therapeutics
UTHR
$26.2B
| $451K | 0.09% |
+1,915
| New | +$389K |
|
|
MREO
98
Mereo BioPharma
MREO
$50.3M
| $431K | 0.09% |
+385,000
| New | +$298K |
|
99
BioNTech
BNTX
$23.5B
| $328K | 0.07% |
2,200
-420
| -16% | -$64.2K |
|
100
Jazz Pharmaceuticals
JAZZ
$16.2B
| $307K | 0.06% |
+1,970
| New | +$303K |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Sectoral Asset Management held 128 positions worth $496M, down 12% from $563M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management's Q2 2022 filing shows 22 new, 39 increased, 44 reduced and 16 closed positions. Its largest new stake was Travere Therapeutics: 232,000 shares worth $5.62M. The largest sale was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $12.4M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Industrials.
- Sectoral Asset Management's largest Q2 2022 buy was Travere Therapeutics: 232,000 shares worth $5.62M.
- Sectoral Asset Management added most to Icon in Q2 2022, an estimated $7.57M increase.
- Sectoral Asset Management's biggest Q2 2022 reduction was Turning Point Therapeutics, Inc. Common Stock, cutting an estimated $8.48M.
- Sectoral Asset Management fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $12.4M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $496M portfolio in Q2 2022.
- Sectoral Asset Management opened 22 new positions and closed 16 in Q2 2022.
- Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $496M.
Based on Sectoral Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.